• 1. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 2. An artificial blood vessel implanted three-dimensional microsystem for modeling transvascular migration of tumor cells?
  Xue-Ying Wang,Ying Pei,Min Xie,Zi-He Jin,Ya-Shi Xiao,Yang Wang,Li-Na Zhang,Yan Li,Wei-Hua Huang Lab Chip, 2015,15, 1178-1187
• 3. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 4. Acetyl group orientation modulates the electronic ground-state asymmetry of the special pair in purple bacterial reaction centers
  P. K. Wawrzyniak,M. T. P. Beerepoot,H. J. M. de Groot,F. Buda Phys. Chem. Chem. Phys., 2011,13, 10270-10279
• 5. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Hydroquinolones
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Quinolines and derivatives Quinolones and derivatives Hydroquinolones

Introduction to 2-Oxo-1,2-dihydroquinoline-6-carbonitrile (CAS No: 63124-11-8)

2-Oxo-1,2-dihydroquinoline-6-carbonitrile, with the chemical formula C?H?N?O, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal research. This compound belongs to the quinoline family, which is well-known for its broad spectrum of biological activities and its role as a key structural motif in numerous therapeutic agents. The presence of a nitrile group at the 6-position and a lactam ring at the 2-position contributes to its unique chemical properties and potential pharmacological applications.

The synthesis of 2-Oxo-1,2-dihydroquinoline-6-carbonitrile typically involves multi-step organic reactions, often starting from readily available quinoline derivatives. The introduction of the nitrile group can be achieved through cyanation reactions, such as the reaction with cyanating agents like trimethylsilyl cyanide (TMSCN) or copper(I) cyanide (CuCN). The lactam formation is commonly accomplished via intramolecular cyclization of appropriately substituted precursors. These synthetic routes highlight the compound's versatility and its potential for further functionalization, making it a valuable intermediate in drug discovery.

Recent advancements in computational chemistry and molecular modeling have enhanced our understanding of the interactions between 2-Oxo-1,2-dihydroquinoline-6-carbonitrile and biological targets. Studies suggest that this compound exhibits promising binding affinity to various enzymes and receptors, which are implicated in critical biological pathways. For instance, preliminary computational studies indicate that it may interact with enzymes involved in inflammation and oxidative stress, suggesting potential therapeutic benefits in conditions such as arthritis and neurodegenerative diseases.

In vitro studies have also explored the antimicrobial properties of 2-Oxo-1,2-dihydroquinoline-6-carbonitrile. The nitrile group and the quinoline core are known to disrupt bacterial cell membranes and inhibit key metabolic pathways. Research has shown that this compound demonstrates efficacy against a range of Gram-positive and Gram-negative bacteria, including some multidrug-resistant strains. These findings are particularly noteworthy given the growing concern over antibiotic resistance worldwide. Further investigation into its mechanism of action could pave the way for novel antimicrobial therapies.

The compound's structural features also make it an attractive scaffold for developing anticancer agents. Quinoline derivatives have been extensively studied for their ability to interfere with DNA replication and transcription in cancer cells. The presence of both a nitrile group and a lactam ring in 2-Oxo-1,2-dihydroquinoline-6-carbonitrile may enhance its ability to bind to DNA or inhibit key enzymes involved in cancer cell proliferation. Preliminary experiments have shown that it can induce apoptosis in certain cancer cell lines, although more research is needed to fully elucidate its anticancer potential.

Another area of interest is the application of 2-Oxo-1,2-dihydroquinoline-6-carbonitrile in neurodegenerative diseases. Quinoline-based compounds have shown promise in treating conditions such as Alzheimer's disease and Parkinson's disease by modulating neurotransmitter levels and protecting against oxidative damage. The unique chemical structure of this compound suggests that it may interact with neurotransmitter receptors or enzymes involved in neuroprotection. Ongoing research aims to explore these possibilities further, with the hope of identifying new treatments for these debilitating conditions.

The pharmacokinetic properties of 2-Oxo-1,2-dihydroquinoline-6-carbonitrile are also under investigation. Understanding how the body processes this compound is crucial for optimizing its therapeutic efficacy and minimizing potential side effects. Preliminary studies suggest that it has a moderate bioavailability and a reasonable half-life, which are favorable characteristics for a drug candidate. However, further studies are needed to assess its metabolic pathways and excretion profiles.

In conclusion, 2-Oxo-1,2-dihydroquinoline-6-carbonitrile (CAS No: 63124-11-8) represents a promising candidate for further development in pharmaceutical applications. Its unique chemical structure, combined with its demonstrated biological activities, makes it a valuable compound for drug discovery efforts. As research continues to uncover new therapeutic possibilities, this compound is poised to play an important role in addressing various medical challenges.

• 79207-68-4(6-amino-1,2-dihydroquinolin-2-one)
• 787510-48-9(2(1H)-Quinolinone,7-(ethylamino)-8-methyl-)
• 1321-40-0(2-(1H)-Quinolinone)
• 59-31-4(2-HYDROXYQUINOLINE)
• 61317-32-6(5-amino-1H-quinolin-2-one)
• 70254-42-1(2-Quinolinol)
• 4053-34-3(2-Hydroxy-6-methylquinoline)
• 104534-80-7(Quinolinone)
• 4053-35-4(7-methyl-1,2-dihydroquinolin-2-one)
• 54904-39-1(6,8-Dimethylquinolin-2(1H)-one)